Side effects, cost, supply, target: four reasons with four trajectories
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
The archive
Page 16 of 170 of this archive, newest first.
What the tirzepatide schedule assumes about a person it has never met
What the published pharmacokinetics permit, what the labels state, and where the two diverge.
The certificate says 2026. The vial in your hand does not say anything.
What happens to traceability when bulk material is subdivided, repackaged and relabelled two or three times before sale.
GL Biochem names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
South Africa pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Nought point nine eight of a dalton: the modification that hides in plain sight
What would be needed to catch each of these, and what it would cost.
FLOW extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The 27-day notice: how a compounding wind-down works in France
The document is four pages. Three of them are about dates.
Halvard & Pike Apothecary of Portland, Maine closes after 22 years
A proper account of an operation that existed, and of what closing it cost.
Sweden health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
Load, not cardio: the distinction the general advice keeps losing
The recommendation survives scrutiny. The reasoning offered for it frequently does not.
Continued treatment against continued placebo: the comparison that settled it
The regain trajectories, arm by arm, with the estimands named.
HbA1c and its lag: what a result three months old is telling you
The assay is not the problem. The interpretation of a lagging integral as a current measurement is the problem.
PeptideMeter result on a Suzhou liraglutide lot lands 4.0 points above the supplier’s stated figure
The result is unremarkable. What the report states alongside it is not.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
The Netherlands pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
Janoshik result on a Zhuhai tirzepatide lot lands 2.5 points above the supplier’s stated figure
A reminder that a purity figure is the output of a method, and that methods differ.
Low endotoxin recovery: the interference nobody looks for
The limit for a parenteral product is calculable from the dose and the body weight in two lines. Almost nobody in this trade performs the calculation.
Tolerability is the ceiling, and the ceiling is personal
An effect is dose-limiting when it prevents adequate intake, prevents normal activity, or produces a risk of its own. Discomfort alone is not the test.
Independent analysis puts a FGP exenatide lot at 95.8%, against 93.2% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Inspectors cite the consolidator trading as Meridian Freight Partners over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What the new Nigeria guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What changed at TFC in April, and what the company says prompted it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The supply gap as a clinical event
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
From the floor in Wuxi: 14 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Japan pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
Guangzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
A vial can be 99.4 per cent pure and not sterile in the same afternoon
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.